Published in Chest on February 01, 1972
Surgical treatment of post-infarction left ventricular pseudoaneurysm: a two-decade experience. Tex Heart Inst J (2007) 1.62
Advantages of colour flow imaging in the diagnosis of left ventricular pseudoaneurysm. Br Heart J (1989) 1.54
Left ventricular free wall rupture: clinical presentation and management. Heart (2000) 1.53
Elective operations for post-infarction left ventricular aneurysms. Thorax (1976) 1.33
Rupture of the myocardium. Occurrence and risk factors. Br Heart J (1985) 1.16
Non-invasive diagnosis of pseudoaneurysm of left ventricle. Br Heart J (1978) 1.04
Ischaemic ventricular aneurysms: true or false? Br Heart J (1988) 1.03
Non-invasive diagnosis of a false left ventricular aneurysm by echocardiography and pulsed Doppler echocardiography. Br Heart J (1980) 1.02
Posterobasal left ventricular aneurysms: clinical results and surgical treatment. Tex Heart Inst J (1984) 1.00
Management of recurrent ventricular pseudoaneurysm. Tex Heart Inst J (1991) 1.00
False aneurysm formation after Salmonella virchow infection of a pre-existent ventricular aneurysm--survival after surgical resection. Postgrad Med J (1989) 0.94
False aneurysm of the left ventricle. Report of four cases and review of surgical management. Ann Surg (1979) 0.89
Surgical treatment of false aneurysm of the left ventricle after myocardial infarction. Thorax (1983) 0.87
Survival after subacute cardiac rupture. Br Heart J (1982) 0.76
Left ventricular pseudoaneurysm. J Geriatr Cardiol (2017) 0.75
Excision of a false left ventricular aneurysm. J R Soc Med (1999) 0.75
Survival of an octogenarian after rupture of the left ventricular free wall caused by myocardial infarction. Tex Heart Inst J (2004) 0.75
Successful management of mechanical complications following acute myocardial infarction--a case report. Korean J Intern Med (1991) 0.75
Unusual symptom in patient with pseudoaneurysm of the left ventricle and review of the literature. Tex Heart Inst J (1982) 0.75
Atrial infarction leading to rupture. Br Heart J (1979) 0.75
Survival after left ventricular free wall rupture in an elderly woman with acute myocardial infarction treated only medically. Case Rep Vasc Med (2012) 0.75
Left ventricle pseudoaneurysm after aortic valvuloplasty. Pediatr Cardiol (2011) 0.75
Unruptured giant left ventricular pseudoaneurysm complicating silent myocardial infarction in a diabetic young adult: left ventricular giant pseudoaneurysm after silent myocardial infarction. Int J Cardiovasc Imaging (2005) 0.75
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis (2001) 12.73
A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation (1975) 10.97
A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute. N Engl J Med (1994) 9.11
Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin Infect Dis (2000) 5.73
Severe candidal infections: clinical perspective, immune defense mechanisms, and current concepts of therapy. Ann Intern Med (1978) 4.15
Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis (2001) 3.75
Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing. Clin Infect Dis (1996) 3.52
Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group. Pediatr Infect Dis J (2000) 3.13
True and false left ventricular aneurysms. Propensity for the altter to rupture. Circulation (1975) 3.12
Susceptibility testing of Cryptococcus neoformans: a microdilution technique. J Clin Microbiol (1992) 3.12
Candida albicans RIM101 pH response pathway is required for host-pathogen interactions. Infect Immun (2000) 3.03
Ocular manifestations of Candida septicemia: review of seventy-six cases of hematogenous Candida endophthalmitis. Medicine (Baltimore) (1974) 2.97
Anomalies associated with coarctation of aorta: particular reference to infancy. Circulation (1970) 2.95
Type 1/Type 2 immunity in infectious diseases. Clin Infect Dis (2000) 2.79
Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun (1995) 2.75
National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis (1999) 2.63
Adherence of Candida to cultured vascular endothelial cells: mechanisms of attachment and endothelial cell penetration. J Infect Dis (1985) 2.61
Response of newly hatched chicks to inanition. Vet Rec (1992) 2.57
National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species. Diagn Microbiol Infect Dis (1998) 2.56
Congenital anomalies involving the coronary sinus. Circulation (1966) 2.29
Expression of specific binding sites on Candida with functional and antigenic characteristics of human complement receptors. J Immunol (1986) 2.28
1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. Clin Infect Dis (1997) 2.14
Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group. Clin Infect Dis (1995) 2.11
Adherence of Candida species to host tissues and plastic surfaces. Rev Infect Dis (1986) 2.11
Right aortic arch. Types and associated cardiac anomalies. Circulation (1974) 2.08
Polysplenia: a review of 146 cases. Pediatr Cardiol (1983) 2.05
Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's disease. Gut (2002) 1.96
Expression of the Candida albicans gene ALS1 in Saccharomyces cerevisiae induces adherence to endothelial and epithelial cells. Infect Immun (1998) 1.96
Congenital cardiac disease associated with polysplenia. A developmental complex of bilateral "left-sidedness". Circulation (1967) 1.96
Relative efficacy of oral analgesics after third molar extraction. Br Dent J (2004) 1.95
The spectrum of transposition of the great arteries: with specific reference to developmental anatomy of the conus. Circulation (1973) 1.93
Quantitation of amphotericin B with use of high-pressure liquid chromatography. J Infect Dis (1977) 1.83
Pathologic changes in aortic-coronary arterial saphenous vein grafts. Circulation (1971) 1.83
Thrombin-induced rabbit platelet microbicidal protein is fungicidal in vitro. Antimicrob Agents Chemother (1993) 1.80
Candida albicans stimulates cytokine production and leukocyte adhesion molecule expression by endothelial cells. Infect Immun (1996) 1.79
Acute pain: individual patient meta-analysis shows the impact of different ways of analysing and presenting results. Pain (2005) 1.79
Sudden death in patients with hypertrophic cardiomyopathy: characterization of 26 patients with functional limitation. Am J Cardiol (1978) 1.78
Dissecting aortic aneurysm associated with congenital bicuspid aortic valve. Circulation (1978) 1.74
Pulmonary vascular sling: report of seven cases and review of the literature. Pediatr Cardiol (1989) 1.68
Modulation of interactions of Candida albicans and endothelial cells by fluconazole and amphotericin B. Antimicrob Agents Chemother (1992) 1.67
Cor triatriatum: study of 20 cases. Am J Cardiol (1975) 1.66
Congenital aneurysms adjacent to the anuli of the aortic and/or mitral valves. Chest (1982) 1.64
Correlation of the antemortem coronary arteriogram and the postmortem specimen. Circulation (1973) 1.64
Invasive candida infections--evolution of a fungal pathogen. N Engl J Med (1991) 1.64
Primary cardiac tumors: experience at the University of Minnesota. Thorac Cardiovasc Surg (1990) 1.61
Synergism of amphotericin B and 5-fluorocytosine for candida species. J Infect Dis (1975) 1.61
Adherence of candida species to intravenous catheters. J Infect Dis (1983) 1.60
Hematogenous candida endophthalmitis in patients receiving parenteral hyperalimentation fluids. J Infect Dis (1981) 1.56
Gabapentin for acute and chronic pain. Cochrane Database Syst Rev (2005) 1.55
Pulmonary arterial aneurysm. A pathologic study of five cases. Chest (1987) 1.54
Cardiac malpositions. An overview based on study of sixty-five necropsy specimens. Circulation (1977) 1.51
Effects on cattle of transport by road for up to 15 hours. Vet Rec (1995) 1.51
Anatomic identification of so-called absent pulmonary artery. Circulation (1978) 1.49
Reduced virulence of HWP1-deficient mutants of Candida albicans and their interactions with host cells. Infect Immun (2000) 1.48
Communication between coronary sinus and left atrium. Br Heart J (1974) 1.48
Imiquimod for the treatment of genital warts: a quantitative systematic review. BMC Infect Dis (2001) 1.47
Diseases of the mitral valve in infancy. An anatomic analysis of 55 cases. Circulation (1971) 1.47
Congenital aneurysm of left atrial appendage. Br Heart J (1981) 1.46
Isolated ventricular septal defect. Development basis for various types and presentation of classification. Chest (1970) 1.46
Elucidating the origins of nosocomial infections with Candida albicans by DNA fingerprinting with the complex probe Ca3. J Clin Microbiol (1999) 1.44
Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J (2001) 1.44
Association of infection due to Candida albicans with intravenous hyperalimentation. J Infect Dis (1978) 1.43
Frequency and location of atherosclerotic plaques in the ascending aorta. J Thorac Cardiovasc Surg (1988) 1.43
Seismocardiographic changes associated with obstruction of coronary blood flow during balloon angioplasty. Am J Cardiol (1991) 1.43
Mechanism of death and prevalence of myocardial ischemic symptoms in the terminal event after acute myocardial infarction. Am J Cardiol (1988) 1.42
Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum. Comparison of fetuses and infants with and without congenital heart disease and patients with hypertrophic cardiomyopathy. Circulation (1979) 1.41
Single dose oral naproxen and naproxen sodium for acute postoperative pain. Cochrane Database Syst Rev (2004) 1.41
Anatomic evidence for spontaneous closure of ventricular septal defect. Circulation (1966) 1.41
Pathologic spectrum of dysplasia of the tricuspid valve. Features in common with Ebstein's malformation. Arch Pathol (1971) 1.40
Association of the acquired bicuspid aortic valve with rheumatic disease of atrioventricular valves. Am J Cardiol (1989) 1.40
De subitaneis mortibus. XX. Cardiac electrical instability in the presence of a left superior vena cava. Circulation (1976) 1.40
Complete heart block following replacement of the aortic valve. Circulation (1966) 1.39
Resistance to platelet microbicidal protein results in increased severity of experimental Candida albicans endocarditis. Infect Immun (1996) 1.39
Intracavitary cardiac neoplasms. A review of fifteen cases. Br Heart J (1966) 1.39
Single dose oral ibuprofen and diclofenac for postoperative pain. Cochrane Database Syst Rev (2000) 1.38
Estimating the cost of nosocomial candidemia in the united states. Clin Infect Dis (2001) 1.38
Specificity and sensitivity of eubacterial primers utilized for molecular profiling of bacteria within complex microbial ecosystems. J Microbiol Methods (2007) 1.37
The development of the interventricular septum of the human heart; correlative morphogenetic study. Chest (1970) 1.36
Effects on sheep of transport by road for up to 24 hours. Vet Rec (1995) 1.34
Cryptococcal intracerebral mass lesions: the role of computed tomography and nonsurgical management. Ann Intern Med (1981) 1.32
Secreted aspartyl proteinases and interactions of Candida albicans with human endothelial cells. Infect Immun (1998) 1.31
Adherence to and damage of endothelial cells by Cryptococcus neoformans in vitro: role of the capsule. Infect Immun (1995) 1.31
Effect of knee joint effusion on quadriceps and soleus motoneuron pool excitability. Med Sci Sports Exerc (2001) 1.30
Spontaneous rupture of a false left ventricular aneurysm following myocardial infarction. Am Heart J (1969) 1.29
Detection of fungemia obscured by concomitant bacteremia: in vitro and in vivo studies. J Clin Microbiol (1982) 1.28
Arterial-esophageal fistulae developing in patients with anomalies of the aortic arch system. Chest (1984) 1.28
Interruption of aortic arch; anatomic patterns and associated cardiac malformations. Am J Roentgenol Radium Ther Nucl Med (1965) 1.28
Anatomic variations in the tetralogy of Fallot. Am Heart J (1971) 1.28
Complete heart block complicating bacterial endocarditis. Circulation (1972) 1.28
The relationship between intramuscular temperature, skin temperature, and adipose thickness during cryotherapy and rewarming. Arch Phys Med Rehabil (2001) 1.27
False aneurysm of the left ventricle secondary to bacterial endocarditis with perforation of the mitral-aortic invervalvular fibrosa. Circulation (1968) 1.27
Candida albicans stimulates endothelial cell eicosanoid production. J Infect Dis (1991) 1.27
Anatomic factors causing respiratory distress in acyanotic congenital cardiac disease. Special reference to bronchial obstruction. Pediatrics (1969) 1.26
Sterol composition of Cryptococcus neoformans in the presence and absence of fluconazole. Antimicrob Agents Chemother (1994) 1.26
The mechanism of balloon angioplasty. Radiology (1980) 1.26
Candidiasis. Infect Dis Clin North Am (1989) 1.26
Aberrant right subclavian artery with left aortic arch: associated cardiac anomalies. Pediatr Cardiol (1993) 1.24
Sterol compositions and susceptibilities to amphotericin B of environmental Cryptococcus neoformans isolates are changed by murine passage. Antimicrob Agents Chemother (1995) 1.24
In vitro determination of optimal antifungal combinations against Cryptococcus neoformans and Candida albicans. Antimicrob Agents Chemother (1995) 1.24